皮肤黑色素瘤的形态学能否解释国际生存差异?来自59个国家2000-2014年诊断的1 578 482名成人的CONCORD-3结果
基于59个国家2000-2014年诊断的1 578 482名成人皮肤黑色素瘤患者,按七类形态学分组估计基于人群的净生存。结节型黑色素瘤占7%至13%,肢端雀斑样黑色素瘤不足2%但在亚洲(6%)和中南美洲(7%)更常见。结节型在所有国家预后最差,性别、年龄和分期仅部分解释结节型和肢端雀斑样型更高的死亡风险。
要点
- 结节型黑色素瘤占7%至13%,肢端雀斑样型不足2%但在亚洲(6%)和中南美洲(7%)更常见。
- 2010-2014年浅表扩散型5年净生存在大洋洲、北美和多数欧洲国家达95%或更高,台湾仅71%。
- 肢端雀斑样型5年净生存范围为66%至95%,结节型在所有国家预后最差。
核心结论
- 结节型和肢端雀斑样型黑色素瘤预后较差,且在亚洲和拉丁美洲更常见,提示需针对特定人群制定卫生政策以提高认识、早期诊断和治疗可及性。
- 性别、年龄和诊断时分期仅部分解释结节型和肢端雀斑样型较浅表扩散型更高的超额死亡风险。
研究设计与样本
- 基于人群的登记研究,纳入59个国家2000-2014年诊断的1 578 482名成人皮肤黑色素瘤患者。
- 按七类形态学分组:恶性黑色素瘤非特指型(ICD-O-3形态学编码8720)、浅表扩散型(8743)、恶性雀斑样型(8742)、结节型(8721)、肢端雀斑样型(8744)、促结缔组织增生型(8745)和其他形态(8722-8723、8726-8727、8730、8740-8741、8746、8761、8770-8774、8780)。
- 采用非参数Pohar Perme估计量估计净生存,按各国或地区单岁年龄、性别和日历年份校正背景死亡率。
- 全年龄生存估计采用国际癌症生存标准权重标准化,并拟合灵活参数模型估计形态学对死亡风险的影响。
主要发现
- 全球结节型黑色素瘤占比范围为7%至13%。
- 肢端雀斑样型黑色素瘤占所有登记不足2%,但在亚洲为6%、中南美洲为7%。
- 总体36%的肿瘤分类为浅表扩散型黑色素瘤。
- 2010-2014年浅表扩散型年龄标准化5年净生存在大洋洲、北美和多数欧洲国家为95%或更高,台湾仅为71%。
- 肢端雀斑样型5年净生存范围为66%至95%,结节型在所有国家预后最差。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: CONCORD-3 highlighted wide disparities in population-based 5-year net survival for cutaneous melanoma during 2000-2014. Clinical evidence suggests marked international differences in the proportion of lethal acral and nodular subtypes of cutaneous melanoma. OBJECTIVES: We aimed to assess whether the differences in morphology may explain global variation in survival. METHODS: Patients with melanoma were grouped into the following seven morphological categories: malignant melanoma, not otherwise specified (International Classification of Diseases for Oncology, third revision morphology code 8720), superficial spreading melanoma (8743), lentigo maligna melanoma (8742), nodular melanoma (8721), acral lentiginous melanoma (8744), desmoplastic melanoma (8745) and other morphologies (8722-8723, 8726-8727, 8730, 8740-8741, 8746, 8761, 8770-8774, 8780). We estimated net survival using the nonparametric Pohar Perme estimator, correcting for background mortality by single year of age, sex and calendar year in each country or region. All-ages survival estimates were standardized using the International Cancer Survival Standard weights. We fitted a flexible parametric model to estimate the effect of morphology on the hazard of death. RESULTS: Worldwide, the proportion of nodular melanoma ranged between 7% and 13%. Acral lentiginous melanoma accounted for less than 2% of all registrations but was more common in Asia (6%) and Central and South America (7%). Overall, 36% of tumours were classified as superficial spreading melanoma. During 2010-2014, age-standardized 5-year net survival for superficial spreading melanoma was 95% or higher in Oceania, North America and most European countries, but was only 71% in Taiwan. Survival for acral lentiginous melanoma ranged between 66% and 95%. Nodular melanoma had the poorest prognosis in all countries. The multivariable analysis of data from registries with complete information on stage and morphology found that sex, age and stage at diagnosis only partially explain the higher risk of death for nodular and acral lentiginous subtypes. CONCLUSIONS: This study provides the broadest picture of distribution and population-based survival trends for the main morphological subtypes of cutaneous melanoma in 59 countries. The poorer prognosis for nodular and acral lentiginous melanomas, more frequent in Asia and Latin America, suggests the need for health policies aimed at specific populations to improve awareness, early diagnosis and access to treatment. What is already known about this topic? The histopathological features of cutaneous melanoma vary markedly worldwide. The proportion of melanomas with the more aggressive acral lentiginous or nodular histological subtypes is higher in populations with predominantly dark skin than in populations with predominantly fair skin. What does this study add? We aimed to assess the extent to which these differences in morphology may explain international variation in survival when all histological subtypes are combined. This study provides, for the first time, international comparisons of population-based survival at 5 years for the main histological subtypes of melanoma for over 1.5 million adults diagnosed during 2000-2014. This study highlights the less favourable distribution of histological subtypes in Asia and Central and South America, and the poorer prognosis for nodular and acral lentiginous melanomas. We found that later stage at diagnosis does not fully explain the higher excess risk of death for nodular and acral lentiginous melanoma compared with superficial spreading melanoma.
引用
- Di Carlo V, Stiller CA, Eisemann N, et al. Does the morphology of cutaneous melanoma help to explain the international differences in survival? Results from 1 578 482 adults diagnosed during 2000-2014 in 59 countries (CONCORD-3). Br J Dermatol. 2022. PMID: 35347700. doi:10.1111/bjd.21274
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。